Clinica de pesquisa e centro de estudos em oncologia ginecológica e mamaria

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Ovarian cancer1 trial

Phase

• Phase 32 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• BeOne Medicines1 trial
• Gilead Sciences1 trial
• Tolmar Inc.1 trial

Running trials

• Recruiting

  BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

  NCT06120283· Phase 1· BeOne Medicines· Source

  Contact: Study Director

• Active, not recruiting

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

  NCT05840211· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

  NCT04906395· Phase 3· Tolmar Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting